ABBVNYSE
AbbVie Inc.
$0.00
0.000.00%
15-min delay
ED
Open—
Prev Close—
Market Cap$521.50B
P/E (TTM)50.80
EPS$10.00
Earnings2027-02-03
DAY RANGE
$0.00$0.00

AbbVie Inc. is a research-based biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative medicines and therapies worldwide. The company maintains a strong focus on immunology, offering treatments like Humira, Skyrizi, and Rinvoq for autoimmune and inflammatory conditions in rheumatology, gastroenterology, dermatology, and related areas. In oncology, it provides therapies such as Imbruvica, Venclexta, Elahere, Epkinly, and Emrelis targeting blood cancers, lymphoma, and lung cancer. AbbVie Inc. also addresses virology with Mavyret for hepatitis C, neuroscience for neurological disorders like Parkinson's, and additional areas including metabolic diseases, cystic fibrosis complications, endometriosis pain, irritable bowel syndrome, chronic constipation, and pancreatic enzyme therapy with Creon, alongside aesthetics products like Botox and Linzess/Constella. Founded in 2013 and headquartered in North Chicago, Illinois, AbbVie Inc. plays a vital role in the healthcare sector by delivering solutions for complex, chronic, and serious health conditions.

SectorHealth Technology
Employees57000
ISINUS00287Y1091
Address1 North Waukegan Road 11 Bermudiana Road, North Chicago, IL, 60064-6400
Key Statistics
Full Stats
Market Cap$521.50B
Enterprise Value$591.97B
P/E Ratio (TTM)50.80
P/S Ratio7.90
P/B Ratio—
Forward P/E49.40
EPS (TTM)$5.81
EPS (FY)$10.00
Revenue (TTM)$66.01B
Profit Margin15.60%
Operating Margin36.18%
ROE15221.82%
Debt/Equity—
Avg Vol (30d)5.4M
Beta (1Y)-0.65
Beta (3Y)-0.01
Beta (5Y)0.19
Shares Out1.77B
Float—
Dividend2.47%
Next Earnings2027-02-03
Short Interest—
52-Week Range
$0.00
$190.75$302.93

Upgrades & Downgrades

Members

Every rating change, who made it, and what it moved from.

Sign in to viewCreate a free account

Free account. No card required.

Grades Consensus

Members

Analyst price targets — high, low, median and where it sits now.

Sign in to viewCreate a free account

Free account. No card required.

Price Target Consensus

Members

Analyst price targets — high, low, median and the upside from here.

Sign in to viewCreate a free account

Free account. No card required.

Ratings Snapshot

Members

DCF, Piotroski, Altman Z and returns scores, in one grade.

Sign in to viewCreate a free account

Free account. No card required.

Forward Estimates

Members

Quarterly revenue and EPS estimates, with the history of beats.

Sign in to viewCreate a free account

Free account. No card required.

Seasonality

Members

How this ticker has traded month by month over the last decade.

Sign in to viewCreate a free account

Free account. No card required.